PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.81%
Positive revenue growth while MRVL is negative. John Neff might see a notable competitive edge here.
9.81%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
15.53%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
15.39%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
15.19%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
15.71%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
14.49%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.32%
Share reduction while MRVL is at 0.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.06%
Dividend growth under 50% of MRVL's 0.89%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
95.43%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
115.37%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
37.03%
10Y revenue/share CAGR under 50% of MRVL's 98.22%. Michael Burry would suspect a lasting competitive disadvantage.
9.05%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
18.09%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
158.94%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
95.19%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
74.36%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
-46.89%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
40.42%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
36.42%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
20.58%
Below 50% of MRVL's 70.42%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
5.27%
5Y equity/share CAGR at 75-90% of MRVL's 6.13%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
-1.05%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
1158.01%
Dividend/share CAGR of 1158.01% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.41%
Dividend/share CAGR of 193.41% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
35.90%
3Y dividend/share CAGR above 1.5x MRVL's 1.30%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.23%
AR growth well above MRVL's 6.07%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.93%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.04%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.17%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-12.29%
We’re deleveraging while MRVL stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.90%
R&D growth drastically higher vs. MRVL's 5.73%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.95%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.